Frontlight ResearchEarly access
Colorectal cancer trials in China
616 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
- Where
- Shanghai
- Age
- 18 years and over
- People
- 100
- Run by
- Fudan University
See details and how to joinNCT06749015 - Phase 2Not yet taking people in ChinaPreoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 44
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06751394 - Phase 3Taking peopleConversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 508
- Run by
- Fudan University
See details and how to joinNCT04687631 - Phase 2Taking peopleShort-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARC
- Where
- Hubei, Wuhan
- Age
- 18 years to 75 years
- People
- 29
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06542588 - Phase 2Taking peopleCtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
- Where
- Chengde, Chengdu, Guiyang, Kunming
- Age
- 18 years to 75 years
- People
- 60
- Run by
- West China Hospital
See details and how to joinNCT06242418 - Phase 2Not yet taking people in ChinaA Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
- Where
- Shanghai
- Age
- 18 years and over
- People
- 120
- Run by
- Tasly Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06724263 - Phase 1Taking peopleClinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 9
- Run by
- Beijing Immunochina Medical Science & Technology Co., Ltd.
See details and how to joinNCT06718738 - Phase 2Taking peopleNanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer
- Where
- Beijing
- Age
- 18 years to 70 years
- People
- 36
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06405139 - Phase 2Taking peopleHDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
- Where
- Chongqing
- Age
- 18 years and over
- People
- 100
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT06709885 - No phaseEnrolling by invitationA Metabolomics-based Study to Explore the Mechanism of Remission of Metabolic Syndrome Radical Resection of Colorectal Cancer
- Where
- Chongqing
- Age
- 18 years and over
- People
- 150
- Run by
- Dong Peng
See details and how to joinNCT06710314 - No phaseTaking peopleClinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer
- Where
- Shenyang
- Age
- 18 years to 75 years
- People
- 352
- Run by
- First Hospital of China Medical University
See details and how to joinNCT06637215 - Phase 2Taking peopleSafety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 46
- Run by
- Dai, Guanghai
See details and how to joinNCT06685276 - No phaseNot yet taking people in ChinaEOCRCPred: an AI Model to Predict Survival in EOCRC Patients After Surgery
- Where
- Shanghai
- Age
- 18 years to 49 years
- People
- 250
- Run by
- Shanghai University of Traditional Chinese Medicine
See details and how to joinNCT06690606 - Phase 3Taking peopleAdjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 180
- Run by
- Sun Yat-sen University
See details and how to joinNCT06520683 - Phase 2Not yet taking people in ChinaSHR-1701 Combined with SHR2554 and BP102 for MCRC
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 20
- Run by
- Fudan University
See details and how to joinNCT06679673 - Phase 1/2Taking peopleBiological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
- Where
- Beijing
- Age
- 16 years to 90 years
- People
- 85
- Run by
- Essen Biotech
See details and how to joinNCT06530303 - No phaseTaking peopleDrug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 200
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT05424692 - Phase 2Not yet taking people in ChinaSHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer
- Where
- Shenyang
- Age
- 18 years to 75 years
- People
- 28
- Run by
- Yunpeng Liu
See details and how to joinNCT06666166 - Phase 2/3Taking peopleA Clinical Study to Evaluate Efficacy and Safety of Serplulimab(HLX10) Combined With Bevacizumab(HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
- Where
- Guangzhou, Hangzhou, Linyi, Shanghai
- Age
- 18 years to 75 years
- People
- 568 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT04547166 - No phaseTaking peopleVirtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision
- Where
- Chongqing
- Age
- 18 years and over
- People
- 620
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT06633133 - Phase 2Taking peopleLiposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer
- Where
- Shijiazhuang
- Age
- 18 years to 75 years
- People
- 173
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT06184698 - No phaseTaking peopleAI-Assisted Non-Contrast CT for Multi-Cancer Screening
- Where
- Shanghai
- Age
- 18 years and over
- People
- 1,000,000
- Run by
- Guo ShiWei
See details and how to joinNCT06632886 - Early phase 1Not yet taking people in ChinaTP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 9
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06619886 - Phase 1Not yet taking people in ChinaA PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
- Where
- Beijing, Beijjing
- Age
- 18 years and over
- People
- 112
- Run by
- Danatlas Pharmaceuticals Co., Ltd
See details and how to joinNCT06614751 - Phase 3Not yet taking people in ChinaFirst-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study
- Where
- Chengdu
- Age
- 18 years and over
- People
- 452
- Run by
- Meng Qiu
See details and how to joinNCT06616259